骨坏死孟德尔随机化分析研究进展

doi:10.3969/j.issn.1009-976X.2025.03.012

摘要/Abstract

摘要： 孟德尔随机化分析是一种用于评估流行病学研究中病因推断的数据分析技术，它利用与疾病暴露因素强相关的遗传变异作为工具变量，评估暴露因素与结局之间因果关系的新流行病学研究方法，旨在减少混杂因素的干扰，提高因果推断的准确性。骨坏死与炎症因子、免疫细胞、端粒长度、肠道菌群及微量营养素之间存在因果关系，而糖尿病与骨坏死之间没有因果关系，这有助于更准确地揭示骨坏死的病因和发病机制，为骨坏死的预防和治疗提供新的思路和方向。本文综述近年国内外关于骨坏死的孟德尔随机化分析文献，分析总结骨坏死与炎症因子、免疫细胞、端粒长度、肠道菌群、微量营养素及糖尿病之间的因果关联。

关键词: 孟德尔随机化分析, 骨坏死, 因果关系, 危险因素

Abstract: Mendelian randomization analysis is a data analysis technique used to evaluate etiological inference in epidemiological studies. It uses genetic variation strongly correlated with disease-related exposure factors as instrumental variables to evaluate the causal relationship between disease exposure factors and outcomes, aiming to reduce the interference of confounding factors and improve the accuracy of causal inference. There is a causal relationship between osteonecrosis and inflammatory cytokines, immunocyte phenotype, telomere length, intestinal flora and micronutrients, while there is no causal relationship between diabetes and osteonecrosis. This can more accurately reveal the etiology and pathogenesis of osteonecrosis in clinical practice, and provide new ideas and directions for the prevention and treatment of osteonecrosis. The literature of Mendelian randomization analysis of osteonecrosis was extensively reviewed in recent years, and the causal association between osteonecrosis and inflammatory cytokines, immunocyte phenotype, telomere length, intestinal flora, micronutrients and diabetes was analyzed and summarized.

Key words: Mendelian randomization analysis, osteonecrosis, causality, risk factors

中图分类号:

R681

庞印权, 杨喜诚, 赵立力. 骨坏死孟德尔随机化分析研究进展[J]. 岭南现代临床外科, 2025, 25(03): 210-215.

PANG Yin-quan, YANG Xi-cheng, ZHAO Li-li. Research progress of Mendelian randomized analysis of osteonecrosis[J]. Lingnan Modern Clinics In Surgery, 2025, 25(03): 210-215.

参考文献

[1] Peng P, Nie Z, Sun F, et al.Glucocorticoids induce femoral head necrosis in rats through the ROS/JNK/c‐Jun pathway[J]. FEBS Open bio, 2021, 11(1): 312-321.
[2] Shah KN, Racine J, Jones LC, et al.Pathophysiology and risk factors for osteonecrosis[J]. Curr Rev Musculoskelet Med, 2015, 8(3): 201-209.
[3] Steffen RT, Athanasou NA, Gill HS, et al.Avascular necrosis associated with fracture of the femoral neck after hip resurfacing: histological assessment of femoral bone from retrieval specimens[J]. J Bone Joint Surg Br, 2010, 92(6): 787-793.
[4] Motta F, Timilsina S, Gershwin ME, et al.Steroid-induced osteonecrosis[J]. J Transl Autoimmun, 2022, 5: 100168.
[5] Hines JT, Jo WL, Cui Q, et al.Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment[J]. J Korean Med Sci, 2021, 36(24): e177.
[6] Wang CJ, Cheng JH, Huang CC, et al.Extracorporeal shockwave therapy for avascular necrosis of femoral head[J]. Int J Surg, 2015, 24: 184-187.
[7] Yu Y, Zhang Y, Wu J, et al.Genetic polymorphisms in IL1B predict susceptibility to steroid-induced osteonecrosis of the femoral head in Chinese Han population[J]. Osteoporos Int, 2019, 30(4): 871-877.
[8] Weinstein RS.Glucocorticoid-induced osteonecrosis[J]. Endocrine, 2012, 41: 183-190.
[9] Baek SH, Kim KH, Lee WK, et al.Abnormal lipid profiles in nontraumatic osteonecrosis of the femoral Head: a comparison with osteoarthritis using propensity score matching[J]. JBJS, 2022, 104(Suppl 2): 19-24.
[10] DMRB. Clinical practice[J]. Postmenopausal osteoporosis [J]. N Engl J Med, 2016, 374(3): 254-62.
[11] Kubo Y, Drescher W, Fragoulis A, et al.Adverse Effects of Oxidative Stress on Bone and Vasculature in Corticosteroid-Associated Osteonecrosis: Potential Role of Nuclear Factor Erythroid 2-Related Factor 2 in Cytoprotection[J]. Antioxid Redox Signal, 2021, 35(5): 357-376.
[12] Pedersen NW, Kiaer T, Kristensen KD, et al.Intraosseous pressure, oxygenation, and histology in arthrosis and osteonecrosis of the hip[J]. Acta Orthop Scand, 1989, 60(4): 415-417.
[13] Huang C, Wen Z, Niu J, et al.Steroid-induced osteonecrosis of the femoral head: novel insight into the roles of bone endothelial cells in pathogenesis and treatment[J]. Front Cell Dev Biol, 2021, 9: 777697.
[14] Jones LC, Mont MA, Le TB, et al.Procoagulants and osteonecrosis[J]. J Rheumatol, 2003, 30(4): 783-791.
[15] Bowden J, Holmes MV.Meta‐analysis and Mendelian randomization: a review[J]. Res Synth Methods, 2019, 10(4): 486-496.
[16] Birney E.Mendelian randomization[J]. Cold Spring Harbor Perspect Med, 2022, 12(4): a041302.
[17] Emdin CA, Khera AV, Kathiresan S.Mendelian randomization[J]. JAMA, 2017, 318(19): 1925-1926.
[18] Levin MG, Burgess S.Mendelian Randomization as a Tool for Cardiovascular Research: A Review[J]. JAMA Cardiol, 2024, 9(1): 79-89.
[19] Zheng J, Yao Z, Xue L, et al.The role of immune cells in modulating chronic inflammation and osteonecrosis[J]. Front Immunol, 2022, 13: 1064245.
[20] Andreev D, Liu M, Weidner D, et al.Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin[J]. J Clin Invest, 2020, 130(9): 4811-4830.
[21] Ma J, Ge J, Gao F, et al.The role of immune regulatory cells in nontraumatic osteonecrosis of the femoral head: a retrospective clinical study[J]. Biomed Res Int, 2019, 2019(1): 1302015.
[22] Cai L, Wang Q, Chen C, et al.Research progress of immune cells regulating the occurrence and development of osteonecrosis of the femoral head[J]. Chin J Reparat Reconstruct Surg, 2022, 36(11): 1428-1433.
[23] Li W, Xu JW, Chai JL, et al.Complex causal association between genetically predicted 731 immunocyte phenotype and osteonecrosis: a bidirectional two-sample Mendelian randomization analysis[J]. Int Journal Surg, 2024, 110(6): 3285-3293.
[24] 柴金莲, 李树栋, 李威, 等. 肠道菌群与药物相关性骨坏死: 两样本双向孟德尔随机化分析[J]. 中国组织工程研究, 2024, 28(27): 4325-4331.
[25] Villa CR, Ward WE, Comelli EM.Gut microbiota-bone axis[J]. Crit Rev Food Sci Nutr, 2017, 57(8): 1664-1672.
[26] 李威, 柴金莲, 贾海峰, 等. 微量营养素与骨坏死的因果关系: 来自双向孟德尔随机试验的证据[J]. 中国组织工程研究, 2024, 28(33): 5308-5314.
[27] Kuribayashi M, Fujioka M, Takahashi KA, et al.Vitamin E prevents steroid-induced osteonecrosis in rabbits[J]. Acta Orthop, 2010, 81(1): 154-160.
[28] Mikami T, Ichiseki T, Kaneuji A, et al.Prevention of steroid-induced osteonecrosis by intravenous administration of vitamin E in a rabbit model[J]. J Orthop Sci, 2010, 15(5): 674-677.
[29] 黎牧帆, 张二洋, 吕雷锋, 等. 维生素E对大鼠早期激素性股骨头缺血性坏死的作用及机制研究[J]. 中国修复重建外科杂志, 2018, 32(11): 1421-1428.
[30] 罗伟东, 蒲彬, 古鹏, 等. 端粒长度与10种常见肌肉骨骼疾病的关系孟德尔随机化分析[J]. 中国组织工程研究, 2025, 29(3): 654-660.
[31] Loi F, Córdova LA, Pajarinen J, et al.Inflammation, fracture and bone repair[J]. Bone, 2016, 86: 119-130.
[32] Oishi Y, Manabe I.Macrophages in inflammation, repair and regeneration[J]. Int Immunol, 2018, 30(11): 511-528.
[33] Goodman SB, Maruyama M.Inflammation, Bone Healing and Osteonecrosis: From Bedside to Bench[J]. J Inflamm Res, 2020, 13: 913-923.
[34] Maruyama M, Rhee C, Utsunomiya T, et al.Modulation of the inflammatory response and bone healing[J]. Front Endocrinol, 2020, 11: 386.
[35] Lu Y, Pei Y, Gao YM, et al.Unraveling the genetic basis of the causal association between inflammatory cytokines and osteonecrosis[J]. Front Endocrinol,2024, 15: 1344917.
[36] Schwartz AV, Backlund JC, Boer IHD, et al.Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study[J]. Lancet Diabetes Endocrinol, 2022, 10(7): 509-518.
[37] Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies[J]. Lancet, 2010, 375(9733): 2215-2222.
[38] Konarski W, Poboży T, Kotela A, et al.Does Diabetes Mellitus Increase the Risk of Avascular Osteonecrosis? A Systematic Review and Meta-Analysis[J]. Int J Environ Res Public Health, 2022, 19(22): 15219.
[39] Lai SW, Lin CL, Liao KF.Real-world database examining the association between avascular necrosis of the femoral head and diabetes in Taiwan[J]. Diabet Care, 2019, 42(1): 39-43.
[40] Li W, Chai J, Li Z, et al.No evidence of genetic causality between diabetes and osteonecrosis: a bidirectional two-sample Mendelian randomization analysis[J]. J Orthop Surg Res, 2023, 18(1): 970.
[41] Meng C, Ren J, Gu H, et al.Association between genetically plasma proteins and osteonecrosis: a proteome-wide Mendelian randomization analysis[J]. Front Genet, 2024, 15: 1440062.
[42] Xu R, Li S, Zhang Y, et al.Causal effects of gut microbiota on the risk of osteomyelitis: a Mendelian randomization study[J]. Front Microbiol, 2024, 15: 1342172.
[43] 邬佳瑜, 李玲, 胡予. 肠道菌群与骨质疏松的关系[J]. 生命的化学, 2022, 42(12): 2200-2207.
[44] Verhaar BJH, Prodan A, Nieuwdorp M, et al.Gut microbiota in hypertension and atherosclerosis: a review[J]. Nutrients, 2020, 12(10): 2982.
[45] Samson AL, Fitzgibbon C, Patel KM, et al.A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells[J]. Cell Death Differ, 2021, 28(7): 2126-2144.
[46] Wang C, Zhu Y, Pan D.Identifying the causal relationship between immune factors and osteonecrosis: a two-sample Mendelian randomization study[J]. Sci Rep, 2024, 14(1): 9371.
[47] 左思力, 龚跃昆. 骨髓间充质干细胞及细胞因子在股骨头坏死治疗中的应用与展望[J]. 中国组织工程研究, 2012, 16(14): 2621-2624.
[48] Molfetta R, Lecce M, Milito ND, et al.SCF and IL-33 regulate mouse mast cell phenotypic and functional plasticity supporting a pro-inflammatory microenvironment[J]. Cell Death Dis, 2023, 14(9): 616.
[49] Yang L, Wu Z, Yin G, et al.Stem cell factor (SCF) protects osteoblasts from oxidative stress through activating c-Kit-Akt signaling[J]. Biochem Biophys Res Commun, 2014, 455(3/4): 256-261.